Uptrend Under Pressure 95
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 95/100 · 7 distribution days (SPY) Oct 27 Full briefing →
View
Simple research view

INCY · Incyte Corporation

$116.60 +2.90% Oct 27 close
Detected setup Wyckoff SOS · Setup Score 83/100

Stand aside — setup invalidated

Setup score 83, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about INCY

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$INCY

Incyte Corporation

Incyte Corporation is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $25B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 3+
$116.60 latest close
Market Structure
Trend structure: downtrend
Latest event: bos (bearish)
Support 99.44–100.30 · 5 touches · strong
Support 102.67–103.45 · 4 touches · moderate
Support 93.54–94.10 · 3 touches · moderate
Support 98.40–98.85 · 3 touches · moderate
Resistance 118.97–119.97 · 3 touches · moderate
Historical record

No active setup in the latest scan — this page shows the last detection Legend AI made for $INCY. Every level, score and criterion below is computed from the Oct 27 close session (1 session old), and may no longer hold.

Historical verdict · setup score 83/100 · data Oct 27 close · 1 session old

Stand aside — setup invalidated

Setup score 83, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$110$120$130AugSepOct$117

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.5 Price > 50-day MA — Price $116.60 vs MA50 $120.99
  • Minervini 2. Revenue growth ≥ 20% YoY — +13.7% YoY
  • O'Neil M: Market in confirmed uptrend — Market phase: uptrend_under_pressure
  • O'Neil I: Institutional sponsorship
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
  • Dennis S1: 20-day Donchian breakout
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails Price > 50-day MA.
  • O'Neil: watch CANSLIM read: 6/8 pass; improvement is still needed.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
62 Neutral
Legend Score · rates the stock Neutral (62/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 84
  • Trend Template (25%) 88
  • Institutional Footprint (20%) 38
  • EPS Growth (15%) 31
  • Quality (SMR-like) (15%) 44

RS rank 83: beating most of the market. Trend template 7/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 38: mild distribution — sellers active. EPS up +1% — growing, but below the 25% leadership bar. Quality 44: weak fundamentals (sales growth 30, return on equity 41, leverage 100). Updated 2026-09-30.

Earnings

Post-earnings setup

Next earnings Monday, October 26, 2026 Report time not confirmed by the source

Deterministic evidence

INCY+2.90%
Sector proxy · XLV-0.06%
Broad market · SPY+0.56%
Same completed session window ending 2026-10-27. INCY was +2.96 points vs XLV. +2.34 points vs SPY.
CatalystUnavailable Stock reactionPositive Sector reactionWeak Opening surge— Event riskEarnings-driven

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+2.90% From the open+4.10% Range position97% GapNo gap
QQQ confirmationConfirming (+1.27%) SMH confirmationConfirming (+3.02%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $116.60 +2.9% Oct 27 close
52W High $132.60 12.1% below high
Wks Since High 12w
Base Depth 18.7%
RS Rank 64 percentile of scan
SMA 50 $120.99
Avg Vol 1,574,012
Rel Vol (Oct 27) 1.42× 0.57× on up days
More stats
52W Low $84.02
Tight Wks 0
Base B3
SMA 200 $107.87
RS Line vs High -8.1%
RS Line Slope -1.8% ▼
Group Rank #17/62
ADR% 2.9%
ATR(14) $3.38 (2.9%)
Vol Pace (live) N/A
A/D Days 10A / 16D
A/D Rating E
VDU Bars 0/10 d
Earnings tomorrow
Position in 52-week range 67thpercentile of the 52-week range
$84.02low
$132.60high

INCY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for INCY.

Create Free Account

Technical Analysis Report Card

$INCY · $116.60 · as of 2026-10-27 · multi-factor read
61
/ 100
Technicals 61/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$120.99 ↓
100-day$117.64 ↓
200-day$107.87 ↑
Bullish (50 > 200)

RSI (14)

Reading50.2 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateImproving
Histogram+0.650

Improving — MACD crossed above its signal line but still below zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width72% · 9.5%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol0.57 · Distribution
Rel volume1.42×
Pocket pivots · 10d0
5d vs 50d vol128%
Heavy vol up / down0 / 1

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is expanding versus its baseline.

  • 1 heavy-volume down day vs 0 up in the last 20 sessions — supply is showing.

Support & Resistance

R · $119.28swing level
R · $130.08swing level
R · $132.6052-week high
Price · $116.60now
S · $115.77swing level
S · $110.56swing level
S · $107.78swing level

Fibonacci · Uptrend swing

23.6%$123.06
38.2% ◄ price here$117.16
50.0%$112.39
61.8%$107.62
78.6%$100.83

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for INCY — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullishVolume distributionRS 83 (leader)
Want this read in a legend's voice? Ask a Legend about INCY
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (83/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid B Trend-template read: fails Price > 50-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $116.60, MA150 $110.53, MA200 $107.87
1.2 150-day MA > 200-day MAMA150 $110.53 vs MA200 $107.87
Failing evidence
1.5 Price > 50-day MAPrice $116.60 vs MA50 $120.99
2. Revenue growth ≥ 20% YoY+13.7% YoY
11/13 checks
O'Neil Watch B CANSLIM read: 6/8 pass; improvement is still needed.
Passing evidence
C: Quarterly EPS acceleration ≥ 25%+70.7% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 83
Failing evidence
M: Market in confirmed uptrendMarket phase: uptrend_under_pressure
I: Institutional sponsorshipData unavailable
6/8 checks
Weinstein Watch B Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $116.60 vs MA200 $107.87
Failing evidence
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
6/7 checks
dennis Watch B Turtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
No breakdown below the 20-day channel20-day low $107.78
Volatility-unit sizing (1N ≈ 1% of equity)1N = $3.39 (2.91% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
6/8 checks
zanger Avoid C Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $134.09-$139.92; trail the rest
Failing evidence
Named Zanger pattern onlyWyckoff SOS is not one of Zanger's six
Breakout volume 1.5-2.0x averageNot confirmed
4/6 checks
zweig Watch B Zweig read: part of his screen passes but not all: Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
EPS growth above the market (≥15% QoQ)+70.7% QoQ — Zweig wants growth above the S&P average
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 15.7x — no PEG or forward P/E stored
Failing evidence
Insider buyingNo insider buying flagged
Monetary conditions: don't fight the FedFed series stored but too thin to read direction
5/8 checks
Livermore Watch B Pivotal-point read: 5/6 structural checks pass; awaiting volume confirmation.
Passing evidence
Price$116.60
Relative strengthRS 83
Failing evidence
Pivotal point cleared on expanding volumeNot confirmed
5/6 checks
Darvas Watch B Box-theory read: 5/6 structural checks pass; awaiting volume confirmation.

mediumBuilding the top of the box (7.1% from 52W high) — watch for a box breakout with volume expansion.

Passing evidence
Price$116.60
Relative strengthRS 83
Failing evidence
Box top broken on heavy volumeNot confirmed
5/6 checks
Wyckoff Watch B Supply-and-demand read: 5/6 structural checks pass; awaiting volume confirmation.

mediumSign of Strength — breakout above trading range on expanding volume. Accumulation phase complete, markup beginning. RS 83.

Passing evidence
Price$116.60
Relative strengthRS 83
Failing evidence
Sign of Strength confirmed on expanding volume1.42x average volume — needs ≥1.4x
5/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Bullish Engulfing — Today's up candle fully engulfs yesterday's down candle — a classic bullish reversal, strongest after a pullback to support.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
114RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -1 E
A: 15 D: 16 Net: -165 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 6/7 met
A 6/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✓ EPS acceleration ≥25% QoQ +71%
✗ Revenue growth ≥20% YoY +14%
✓ Gross margin ≥30% 93%
✓ ROE ≥17% 30%
✓ RS rating ≥80 (leadership) 83
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -12.1%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis (historical)

Wyckoff SOS Historical replay: +20% before −8% within 40 sessions: 15% (n=225) · source bars 2024-11-01–2026-10-26 · avg +0.3% per setup (+0.04R) ⚠ 3rd-stage base
83 setup score
RS Score 83
Trend template 7/8
CANSLIM 85.2* (B)
range low: 94.743 range high: 118.654 range pct: 0.252 sos thrust: 0.056 sos vol ratio: 2.102 sos bars ago: 7 near lps: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS · schematic

SOS: breakout above range_high=118.65, thrust=5.6%, vol=2.1x avg, lps=near, 7 bars ago | Strong trend (7/8) | Top RS (83) | High-confidence pattern (95%) | Stage 2 | Readiness 79/100 (watch) | CANSLIM 85.2 (B) | ⚠ 3rd-stage base

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

4/7 universals met
  • Clear of earnings — not met in 1 days — event risk
  • A relative-strength leader — partly met RS rank 64 — middling
  • Volume confirms — partly met 1.1× average — light
  • Asymmetric reward — met Met — levels are a Pro detail
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
  • Not chasing (in range) — met Met — levels are a Pro detail
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $116.60 vs SMA150 $110.53 / SMA200 $107.87
SMA 150 above SMA 200 SMA150 $110.53 vs SMA200 $107.87
SMA 200 trending up Slope +1.33 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $120.99
Price above SMA 50 $116.60 vs SMA50 $120.99
30%+ above 52-week low +38.8% from $84.02
Within 25% of 52-week high -12.1% from $132.60
RS score above 70 RS 83

Fundamentals

52W Range
67%
Mkt Cap SEC
25.3B
EPS QoQ
+71%
Rev YoY
+14%
ROE
30%
Gross Margin
93%
D/E
0.01
EPS TTM
$7.85
P/E TTM
14.9x
Insider
No Buy

Company

Company profile
Incyte Corporation
INCY · NASDAQ · Health Technology · Pharmaceuticals: Major
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 85.2* CANSLIM * disqualified on M
C · Curr. EPS
100
A · Annual EPS
84
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
83
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
76
W. Support
$90.08
W. Resist
$132.60
Weekly Structure

Scan History

Sep 25: 71 (Wyckoff SOS)Sep 28: 82 (Trend Only)Sep 29: 73 (Wyckoff SOS)Sep 30: 83 (Wyckoff SOS)83
Sep 30
Wyckoff SOS
83
Sep 29
Wyckoff SOS ✓ Gate
73 -5.4%
Sep 28
Trend Only ✓ Gate
82 -6.6%
Sep 25
Wyckoff SOS ✓ Gate
71 -5.9%

Latest News

Headlines for INCY
Loading headlines…

Get the full picture on INCY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial